F
FORTRESS BIOTECH INC
NASDAQ: FBIO (Fortress Biotech, Inc.)
Kemas kini terakhir: 1 jam lalu2.53
0.01 (0.40%)
| Penutupan Terdahulu | 2.52 |
| Jumlah Dagangan | 220,469 |
| Harga / Pendapatan (P/E Ke hadapan) | 1.23 |
| Harga / Jualan (P/S) | 1.18 |
| Harga / Buku (P/B) | 0.510 |
| Julat 52 Minggu |
| Margin Keuntungan | -71.24% |
| Margin Operasi (TTM) | -169.85% |
| EPS Cair (TTM) | -2.13 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 228.52% |
| Nisbah Semasa (MRQ) | 1.72 |
| Aliran Tunai Operasi (OCF TTM) | -74.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -50.02 M |
| Pulangan Atas Aset (ROA TTM) | -32.37% |
| Pulangan Atas Ekuiti (ROE TTM) | -746.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Fortress Biotech, Inc. | Bercampur | Menaik |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.64 |
|
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 21.11% |
| % Dimiliki oleh Institusi | 16.39% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Opaleye Management Inc. | 30 Jun 2026 | 890,000 |
| Mackenzie Financial Corp | 30 Jun 2026 | 555,676 |
| Gsa Capital Partners Llp | 30 Jun 2026 | 458,472 |
| Shikiar Asset Management Inc | 30 Jun 2026 | 305,469 |
| Bridgeway Capital Management, Llc | 30 Jun 2026 | 177,368 |
| Hb Wealth Management, Llc | 30 Jun 2026 | 116,675 |
| Kestra Advisory Services, Llc | 30 Jun 2026 | 116,235 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |